Table 1 Clinical and histopathological characteristics
Characteristics | Normal range | Expressed | All patients (n = 1209) | Patients with the five major histological subtypes (n = 1039) |
|---|---|---|---|---|
Age | - | M (Q1, Q3) | 54.00 (47.00, 61.00) | 54.00 (48.00, 61.00) |
AFP | 0–9 ng/mL | M (Q1, Q3) | 3.06 (1.95, 4.13) | 2.94 (1.90, 3.98) |
CEA | 0–5 ng/mL | M (Q1, Q3) | 1.39 (0.88, 2.28) | 1.41 (0.89, 2.30) |
CA-125 | 0–35 U/mL | M (Q1, Q3) | 118.10 (34.60, 562.85) | 158.30 (44.87, 705.60) |
CA-19-9 | 0–37 U/mL | M (Q1, Q3) | 13.52 (7.13, 27.60) | 14.39 (7.48, 29.29) |
CA-72-4 | 0−6.9 U/mL | M (Q1, Q3) | 5.77 (2.02, 17.82) | 6.98 (2.34, 21.83) |
HE4 | < 140 pmol/L | M (Q1, Q3) | 110.50 (59.54, 352.50) | 137.70 (68.57, 387.74) |
Subtypes | - | n (%) | 1209 (100.00%) | 1039 (100.00%) |
 HGSC | - | n (%) | 645 (53.35%) | 645 (62.08%) |
 MC | - | n (%) | 79 (6.53%) | 79 (7.60%) |
 CC | - | n (%) | 133 (11.00%) | 133 (12.80%) |
 EN | - | n (%) | 110 (9.10%) | 110 (10.59%) |
 LGSC | - | n (%) | 72 (5.96%) | 72 (6.93%) |
 others | - | n (%) | 170 (14.06%) | 0 (0.00%) |